fbpx Skip to content


More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro® to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression. 

There is no better way to grow a corporate practice than having the newest and most advanced technology. The AdaptDx makes my practice stand out from other practices.

Eric Botts Eric Botts, OD

I’ve had fellow practitioners that have said, ‘I didn’t know this was out here’ about the AdaptDx. But once you see the science behind the device, you realize what it can do for your practice and AMD patients. It becomes clear how much easier it is to detect AMD earlier and to track its progression. We, as Vision Source doctors, tend to practice more comprehensive eye care over just refractions and this becomes increasingly effortless with the AdaptDx dark adaptometer.

DonnaShotwell Donna Shotwell, OD

The AdaptDx is especially useful for optometrists and general ophthalmologists who see many patients with “normal” clinical exams, since it can help you identify subclinical AMD up to three years before clinical onset. With the AdaptDx, you will be in the front line in detecting these patients and will be able to carefully monitor and treat those with subclinical AMD.

Dr. Shawn Lewis1 Shawn Lewis, MD

The AdaptDx is a complete paradigm shift in the management and vision loss prevention of AMD. We no longer have the "watch & wait" approach with AMD. Our new proactive approach to this sight threatening disease is utilizing the AdaptDx to help us diagnose AMD due to physiological changes that occur YEARS before any drusen and structural changes are visible. Then, we start patients on a treatment plan and follow-up care significantly earlier, resulting in greatly improved outcomes for our patients!!

Harry Landsaw Harry Landsaw, OD

We have a large retirement population here in Myrtle Beach, so we see a lot of AMD. We invested in the AdaptDx because we know it’s going to help us take better care of our AMD patients, as well as identify so many others who are at risk for developing this devastating disease.

Tammy Tully 2 Tammy Tully, OD

Dark adaptation testing has been a great addition to my office. This device helps me find patients with AMD much sooner than we've ever been able to do. We know that 1 out of 3 Americans over the age of 75 has some form of AMD. But why wait until it's obvious to start therapy?

Jacob Olding, OD Jacob Olding, OD

If you had a crystal ball to predict glaucoma, diabetic retinopathy or AMD, would you not take advantage of it? We have early diagnostic strategies for all three. Ganglion cell loss and capillary density reduction are sentinels for glaucoma and diabetic retinopathy, respectively. Impaired dark adaptation is the gold standard biomarker for subclinical AMD.

Leo Semmes, OD, FAAO Leo Semes, OD, FAAO

Our doctors decided that we should be doing AMD screening for our patients over the age of 65, no matter what. Photos and looking at the macula is just not enough. If you look at the statistics, it makes more sense to do an AdaptDx test on this population than it does to take a tonometry reading to screen for glaucoma!! We decided we wanted to be more proactive and take better care of our patients. Using the AdaptDx to measure dark adaptation function, the earliest sign of AMD, enables us to do just that.

Laurie Sorrenson, OD, FAAO Laurie Sorrenson, OD, FAAO

If you want to impact your patient base in a very positive way by diagnosing and treating macular degeneration at the earliest stages possible to best preserve long term vision, then the AdaptDx is an absolute necessity. There is no other way to detect impairment consistent with AMD so early, including by the best dilated examination and imaging you can give as an eye doctor. Think of it this way…you go to your PCP once per year. And once per year your PCP orders lab work to look for disease that is asymptomatic and undetectable to them in any other way in the early stages (high cholesterol, diabetes, thyroid dysfunction). This is what the AdaptDx can do for your patients.

AmandaLegge_OD Amanda Legge, OD

I have been in eye care since the late 90s and I remember that macular degeneration was just a condition that was very difficult to detect and even once detected, it was difficult to do anything about it. So, essentially, we were just watching patients go blind. Now that we have the AdaptDx, it’s made a world of a difference in diagnosing patients.

Dannette Lammert Dannette Lammert, OD